1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Next Science Limited
  6. News
  7. Summary
    NXS   AU0000041329

NEXT SCIENCE LIMITED

(NXS)
  Report
Delayed Australian Stock Exchange  -  02:10 2022-08-16 am EDT
0.9850 AUD   +2.60%
07/25NEXT SCIENCE : Investor Presentation - Q2 2022
PU
05/27Next Science CEO to Resign Before June 30, 2023
MT
05/27TRANSCRIPT : Next Science Limited - Shareholder/Analyst Call
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Transcript : Next Science Limited - Shareholder/Analyst Call

05/27/2022 EDT
Well, good morning, everyone, and good morning to those who are in the room here in Sydney, and good morning to those who are joining us online. My name is Mark Compton, I'm the Chair of Next...


© S&P Capital IQ 2022
All news about NEXT SCIENCE LIMITED
07/25NEXT SCIENCE : Investor Presentation - Q2 2022
PU
05/27Next Science CEO to Resign Before June 30, 2023
MT
05/27TRANSCRIPT : Next Science Limited - Shareholder/Analyst Call
CI
05/26Next Science Limited's Judith Mitchell to Step Down as Chief Executive Officer
CI
05/19Next Science Secures Australia, New Zealand Distributor for Wound Dressing Product
MT
05/18Next Science Limited Signed Multi-Year Distribution Agreement with Oraderm Pharmaceutic..
CI
05/10New Study Finds XPERIENCE™ No Rinse Solution Has Persistent Efficacy Against Both..
BU
05/10Next Science Xperience(Tm) No Rinse Solution Shows Persistent Efficacy Against Both Pla..
CI
04/28Australian Shares End Three-Day Losing Streak on Boost from Miners
MT
04/27Next Science Posts 31% Growth in Q1 Product Revenue
MT
More news
Financials (USD)
Sales 2022 16,4 M - -
Net income 2022 -6,06 M - -
Net cash 2022 11,7 M - -
P/E ratio 2022 -17,5x
Yield 2022 -
Capitalization 148 M 148 M -
EV / Sales 2022 8,34x
EV / Sales 2023 4,44x
Nbr of Employees -
Free-Float 51,2%
Chart NEXT SCIENCE LIMITED
Duration : Period :
Next Science Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEXT SCIENCE LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 0,69 $
Average target price 1,35 $
Spread / Average Target 95,7%
EPS Revisions
Managers and Directors
Judith Mitchell Chief Executive Officer, Director & MD
Jacqueline Butler Chief Financial Officer
Mark R. Compton Non-Executive Chairman
Matthew Myntti Chief Technology Officer
Jon Swanson Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
NEXT SCIENCE LIMITED-20.88%145
JOHNSON & JOHNSON-2.91%436 680
ELI LILLY AND COMPANY13.66%298 298
PFIZER, INC.-15.75%279 215
ROCHE HOLDING AG-16.14%277 502
ABBVIE INC.5.09%251 582